Junling Li

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification

Jun Guo, Lu Si, Yan Kong et al. · Journal of Clinical Oncology · 2011 · 680 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents

Xifan Wang, Songtao Yang, Shenghui Li et al. · Gut · 2020 · 567 citations · Full text

Life Sciences, Microbiology, Nephrology +17

Angle and polarization estimation using ESPRIT with a polarization sensitive array

Junling Li, R.T. Compton · IEEE Transactions on Antennas and Propagation · 1991 · 251 citations

Engineering, Electrical Engineering, Antennas +15

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

Zhouguang Hui, Yu Men, Chen Hu et al. · JAMA Oncology · 2021 · 230 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

Yuankai Shi, Junling Li, Shucai Zhang et al. · PLoS ONE · 2015 · 205 citations · Full text

Medicine, Molecular Medicine, Oncology +14